摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-[1-(phenylmethyl)-4-piperidinyl]benzenamine | 143866-87-9

中文名称
——
中文别名
——
英文名称
4-[1-(phenylmethyl)-4-piperidinyl]benzenamine
英文别名
4-[l-(phenylmethyl)-4-piperidinyl]-benzenamine;4-[1-(Phenylmethyl)-4-piperidinyl]-benzenamine;4-(1-benzylpiperidin-4-yl)aniline
4-[1-(phenylmethyl)-4-piperidinyl]benzenamine化学式
CAS
143866-87-9
化学式
C18H22N2
mdl
——
分子量
266.386
InChiKey
ULWHSJVUTMIYQT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    417.0±45.0 °C(Predicted)
  • 密度:
    1.099±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    20
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    29.3
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] MTP INHIBITING ARYL PIPERIDINES OR PIPERAZINES SUBSTITUTED WITH 5-MEMBERED HETEROCYCLES<br/>[FR] PIPERIDINES D'ARYLE OU PIPERAZINES SUBSTITUEES PAR DES HETEROCYCLES A 5 RAMIFICATIONS INHIBANT LA MTP
    申请人:JANSSEN PHARMACEUTICA NV
    公开号:WO2005085226A1
    公开(公告)日:2005-09-15
    The present invention is concerned with novel aryl piperidine or piperazine compounds substituted with certain 5-membered heterocycles having apoB secretion/MTP inhibiting activity and concomitant lipid lowering activity. The invention further relates to methods for preparing such compounds, pharmaceutical compositions comprising said compounds as well as the use of said compounds as a medicine for the treatment of hyperlipidemia, obesity and type II diabetes (Formula (I)). The invention further relates to methods for preparing such compounds, pharmaceutical compositions comprising said compounds as well as the use of said compounds as a medicine for the treatment of atherosclerosis, pancreatitis, obesity, hyper­triglyceridemia, hypercholesterolemia, hyperlipidemia, diabetes and type II diabetes.
    本发明涉及新颖的芳基哌啶或哌嗪化合物,其被某些含有apoB分泌/MTP抑制活性和伴随的降脂活性的5-成员杂环取代。该发明还涉及制备这种化合物的方法,包括所述化合物的药物组合物以及将所述化合物用作治疗高脂血症、肥胖症和2型糖尿病的药物的用途(公式(I))。该发明还涉及制备这种化合物的方法,包括所述化合物的药物组合物以及将所述化合物用作治疗动脉粥样硬化、胰腺炎、肥胖症、高甘油三酯血症、高胆固醇血症、高脂血症、糖尿病和2型糖尿病的药物的用途。
  • POLYARYLCARBOXAMIDES USEFUL AS LIPID LOWERING AGENTS
    申请人:Meerpoel LIEVEN
    公开号:US20070082888A1
    公开(公告)日:2007-04-12
    Polyarylcarboxamide compounds of formula (I) are useful as lipid lowering agents.
    化合物式为(I)的聚芳基羧酰胺化合物可用作降脂药物。
  • Lipid Lowering Biphenylcarboxamides
    申请人:Meerpoel Lieven
    公开号:US20080081813A1
    公开(公告)日:2008-04-03
    Biphenylcarboxamide compounds of formula (I) methods for preparing such compounds, pharmaceutical compositions comprising said compounds as well as the use of said compounds as a medicine for the treatment of hyperlipidemia, obesity and type II diabetes.
    本发明提供了一种公式(I)的联苯基甲酰胺化合物,以及制备这种化合物的方法、包含该化合物的制药组合物以及将该化合物作为治疗高脂血症、肥胖症和2型糖尿病的药物的用途。
  • POLYARYLCARBOXAMIDES USEFUL AS LIPID LOWERING AGENTS
    申请人:Meerpoel Lieven
    公开号:US20080125412A1
    公开(公告)日:2008-05-29
    Polyarylcarboxamide compounds of formula (I) are useful as lipid lowering agents.
    公式(I)的聚芳基羧酰胺化合物可用作降脂剂。
  • Lipid lowering biphenylcarboxamides
    申请人:Janssen Pharmaceutica NV
    公开号:US07642378B2
    公开(公告)日:2010-01-05
    Biphenylcarboxamide compounds of formula (I) methods for preparing compounds of formula (I), pharmaceutical compositions comprising compounds of formula (I) as well as the use of compounds of formula (I) as a medicine for the treatment of hyperlipidemia, obesity and type II diabetes.
    公式(I)的联苯基甲酰胺化合物,制备公式(I)化合物的方法,包含公式(I)化合物的药物组合物,以及将公式(I)化合物用作治疗高脂血症、肥胖症和2型糖尿病的药物的用途。
查看更多